Pharma Pulse 5/19/25: Navigating the Payer-Health System Nexus: A Strategic Imperative for Biopharma Commercial Success; Advocate for Change to Address Pharmacy Burnout
Navigating the Payer-Health System Nexus: A Strategic Imperative for Biopharma Commercial Success
Biopharma companies must adopt integrated strategies that engage both payers and health systems—each now powerful, parallel decision-makers—to overcome hidden barriers like “shadow formularies” and ensure successful therapeutic adoption in today’s vertically integrated healthcare landscape, according to a feature in Pharmaceutical Executive.
Advocate for Change to Address Pharmacy Burnout
A Pharmacy Times article emphasizes that addressing widespread pharmacist burnout—driven by chronic workplace stress, staffing shortages, and unrealistic expectations—requires both individual self-care and systemic advocacy for better working conditions to protect professionals and ensure patient safety.
How NIH Funding Cuts are Affecting Academic Research
In an interview with Applied Clinical Trials, Harvard medical student and researcher Michael Liu discusses how recent NIH funding cuts—totaling $1.8 billion and disproportionately impacting early career training grants and institutions nationwide—are threatening the future of biomedical research and ongoing clinical trials, especially those serving marginalized populations.
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
A federal jury found that Amgen violated antitrust laws by using an illegal bundling scheme to favor its cholesterol drug Repatha over Regeneron’s Praluent, ordering Amgen to pay over $400 million in damages.
RFK Jr's HHS to end routine COVID vaccine guidance for children, pregnant women: report
The Department of Health and Human Services, under Secretary Robert F. Kennedy Jr., plans to end routine federal COVID-19 vaccine recommendations for children and pregnant women, signaling a major policy shift and departure from previous public health guidance.
